Quantcast
Last updated on April 23, 2014 at 11:05 EDT

Latest Diabetic retinopathy Stories

2010-10-12 14:01:16

The number of Medicare recipients undergoing treatment for retinal conditions nearly doubled between 1997 and 2007, with significant shifts in the types of procedures most commonly performed, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals. "Retinal disease is highly prevalent among older individuals, and both age-related macular degeneration (AMD) and diabetic retinopathy account for more than half the irreversible blindness in older...

2010-09-20 22:36:54

St. Jude research results help build a foundation for the next generation of therapies using cell-replacement strategies to restore vision lost to the retinal degeneration associated with glaucoma, diabetic retinopathy and age-related macular degeneration New research led by St. Jude Children's Research Hospital investigators adds to evidence that the Six3 gene functions like a doorman in the developing brain and visual system, safeguarding the future retina by keeping the region where the...

044e88bf44542861db364b47d959d9f91
2010-09-13 09:40:00

International pharmaceutical company AstraZeneca will team up with University College London (UCL) with the hopes of using stem cells to develop medicine that will help repair the eyesight of those suffering from diabetic retinopathy (DR), the firm announced in a Monday press release. As part of the agreement, the London-based biologics corporation will team with researchers at the UCL Institute of Ophthalmology over the next three years. Together, they will work to "identify new therapeutic...

2010-08-18 06:00:00

MOUNTAIN VIEW, Calif., Aug. 18 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the receipt of issuance of U.S. Patent No. 7,771,417, titled "Laser System with Short Pulse Characteristics And Its Method Of Use." This patent applies to the company's MicroPulse(TM) technology which provides the ophthalmologist with fine dose control of laser energy during eye surgery. Ophthalmologists are using MicroPulse technology to treat patients suffering from diabetic...

2010-08-10 23:25:03

Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA. Diabetic retinopathy (damage to the retina caused by complications of diabetes mellitus) is the leading cause of new cases of legal blindness among adults 20 to 74 years of age in the United States. Diabetes-related blindness costs the United States...

2010-07-21 22:46:00

GREENWOOD VILLAGE, Colo., July 21 /PRNewswire-FirstCall/ -- Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE) today announced the initiation of a Phase II clinical trial of Optina(TM) for the treatment of diabetic macular edema, an early stage of diabetic retinopathy. Diabetic macular edema is responsible for most vision loss in patients with diabetes mellitus. Ampio Pharmaceuticals has completed a formal agreement with St Michael's Hospital, Toronto, Canada as a final step for...

2010-07-14 08:00:00

YINCHUAN, China, July 14 /PRNewswire-Asia/ -- Recently, Xinhua Website reported about Dr. Nie Wentao's nutrition intervention technology for type 1 diabetes mellitus. Dr. Nie Wentao's diabetic treatment technology is becoming a mainstream technology for diabetes treatment, so it aroused widespread concern in China. Dr. Nie Wentao, having engaged in the study of nutrition interventions on diabetes mellitus for a long period, has great influence in the field of diabetes treatment in China....

2010-07-01 00:27:00

LEUVEN, Belgium, July 1, 2010 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress....

2010-06-30 13:24:45

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans. Intensive blood sugar control reduced the progression of diabetic retinopathy compared with standard blood sugar control, and combination lipid therapy with a fibrate and statin also reduced disease progression compared with statin therapy alone. However, intensive blood pressure...

2062308097c03805998668d01275618a1
2010-06-25 09:31:26

Resveratrol inhibits formation of damaging blood vessels in mouse retina Resveratrol "” found in red wine, grapes, blueberries, peanuts and other plants "” stops out-of-control blood vessel growth in the eye, according to vision researchers at Washington University School of Medicine in St. Louis. The discovery has implications for preserving vision in blinding eye diseases such as diabetic retinopathy and age-related macular degeneration, the leading cause of blindness in...